Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-07-000438
Filing Date
2007-02-22
Accepted
2007-02-22 13:47:48
Documents
4
Group Members
DANIEL S. LOEBTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING t022207b.txt SC 13D 27067
3 LETTER t022207c.txt EX-99.1 2888
4 JOINT FILING AGREEMENT t022207d.txt EX-99.2 2658
5 POA t022207e.txt EX-99.3 4608
  Complete submission text file 0000899140-07-000438.txt   39196
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

EIN.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-81801 | Film No.: 07641432
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D